Vascular function in women: when studying perimenopause is peri important.
Vascular function in women: when studying perimenopause is peri important.
复制标题
女性的血管功能:在研究围绝经期时非常重要。
DOI:
10.1113/ep091066
复制
发表时间:
2023
影响因子:
2.7
通讯作者:
Lefferts,WesleyK
中科院分区:
文献类型:
--
作者:
DuBose,LyndseyE;Lefferts,WesleyK
The menopause transition is a time of accelerated cardiovascular aging and increased susceptibility to chronic diseases including cardiovascular disease (CVD). Growing data support a cardiovascular contribution to brain aging however, characterization of this in women remains unclear. Ruediger et al., characterized group differences in peripheral and cerebrovascular function and their respective associations with sex hormones and nitric oxide bioavailability in healthy middle-aged premenopausal (n= 10), early postmenopausal (n= 15) and late postmenopausal (n= 14) women (Ruediger et al., In Press). The authors should be applauded for conducting this comprehensive study and have taken an important step towards closing a critical gap in knowledge. Accordingly, we wish to highlight the importance of considering (i) the menopausal transition as a period of accelerated risk and clinical versus statistical significance,(ii) subject characteristics that may alter vascular aging trajectories, and (iii) the paucity of data on cerebrovascular hemodynamics during menopause and importance of considering differing vascular methodology.First, the menopause transition is an inherently physiologically dynamic period. Crosssectional studies that exclude a portion of individuals (eg, perimenopausal women) cannot account for the dynamic physiological changes during the menopause transition. Crosssectional studies that exclude perimenopausal women also limit the distribution of hormone, reducing the ability to detect correlations between hormones and vascular outcomes. Gonadotropins begin to rise early in the menopause transition prior to declines in estradiol; however, these changes are accelerated around the final menstrual period. Increases in aortic stiffness are accelerated within one year prior to the final menstrual period and progressive reductions in endothelial function begin in early perimenopause but accelerate in late perimenopause (Samargandy et al., 2020; Moreau et al., 2020). Experimental data suggest that estrogen-deficiency contributes to reductions in endothelial function with menopause and demonstrate a stronger association between follicle stimulating hormone and peripheral vascular function in women, suggesting additional mechanisms contribute (Moreau et al., 2020). These data are important to consider within the context of findings by Ruediger et